# FDA recall D-0879-2023

> **Ferring Pharmaceuticals Inc** · Class II · drug recall initiated 2023-06-12.

## Product

Endometrin (progesterone) Vaginal Insert 100mg, packaged in a carton of 21 vaginal inserts with 21 disposable vaginal applicators, Manufactured for: Ferring Pharmaceuticals Inc., Parsippany, NJ  NDC# 55566-6500-03

## Reason for recall

cGMP deviations: potential for Microbial Contamination of Non-Sterile Products

## Distribution

USA Nationwide

## Key facts

- **Recall number:** D-0879-2023
- **Recalling firm:** Ferring Pharmaceuticals Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-06-12
- **Report date:** 2023-07-05
- **Termination date:** 2024-08-05

- **Voluntary/Mandated:** N/A
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0879-2023

## Citation

> AI Analytics. FDA recall D-0879-2023. Retrieved 2026-06-24 from https://api.ai-analytics.org/recall/D-0879-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*